Wei-Wen Su Selected Research

Chronic Hepatitis B

3/2024	Phase 1 Trial of the Safety, Pharmacokinetics, and Antiviral Activity of EDP-514 in Untreated Viremic Chronic Hepatitis B Patients.
1/2024	Increased prevalence but decreased survival of nonviral hepatocellular carcinoma compared to viral hepatocellular carcinoma in recent ten years.
1/2021	Real-world experience of switching from tenofovir disoproxil fumarate to tenofovir alafenamide in patients with chronic hepatitis B: a retrospective study.
12/2020	Ropeginterferon alfa-2b every 2 weeks as a novel pegylated interferon for patients with chronic hepatitis B.
7/2018	Phase IV randomized clinical study: Peginterferon alfa-2a with adefovir or entecavir pre-therapy for HBeAg-positive chronic hepatitis B.
12/2016	Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wei-Wen Su Research Topics

Disease

23	Chronic Hepatitis C 04/2024 - 01/2010
18	Hepatocellular Carcinoma (Hepatoma) 04/2024 - 09/2005
13	Fibrosis (Cirrhosis) 04/2024 - 09/2012
12	Infections 03/2024 - 02/2009
11	Neoplasms (Cancer) 04/2024 - 09/2005
6	Chronic Hepatitis B 03/2024 - 12/2016
6	Glaucoma 09/2022 - 01/2018
6	Hemorrhage 04/2022 - 10/2005
5	Hepatitis C 01/2024 - 12/2018
5	Liver Cirrhosis (Hepatic Cirrhosis) 01/2024 - 10/2010
5	Cataract (Cataracts) 07/2023 - 01/2011
4	Virus Diseases (Viral Diseases) 04/2023 - 04/2021
4	Disease Progression 12/2020 - 10/2008
3	Liver Diseases (Liver Disease) 01/2024 - 04/2021
3	Non-alcoholic Fatty Liver Disease 01/2024 - 05/2015
3	Hepatitis 01/2024 - 02/2009
3	Open-Angle Glaucoma (Glaucoma, Open Angle) 07/2023 - 05/2007
3	Angle-Closure Glaucoma (Glaucoma, Angle Closure) 10/2021 - 08/2004
2	Diabetes Mellitus 04/2024 - 01/2022
2	Hyperlipidemias (Hyperlipidemia) 04/2024 - 01/2023
2	Obesity 01/2023 - 07/2019
2	Inflammation (Inflammations) 04/2022 - 12/2020
2	Chronic Kidney Failure (Chronic Renal Failure) 08/2021 - 01/2021
2	Low Tension Glaucoma 01/2021 - 05/2007
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 07/2019 - 01/2019
2	Insulin Resistance 05/2015 - 01/2010
2	Peptic Ulcer (Peptic Ulcers) 06/2012 - 10/2011
2	Carcinogenesis 02/2012 - 05/2006
1	Liver Neoplasms (Liver Cancer) 04/2024
1	Communicable Diseases (Infectious Diseases) 01/2024
1	Hyperbilirubinemia 04/2023
1	Colorectal Neoplasms (Colorectal Cancer) 04/2022
1	Mydriasis 04/2022
1	Kidney Diseases (Kidney Disease) 01/2022
1	Chronic Renal Insufficiency 01/2022
1	Coinfection 10/2021
1	Hypersensitivity (Allergy) 07/2021
1	Allergic Conjunctivitis (Giant Papillary Conjunctivitis) 07/2021
1	Conjunctivitis 07/2021
1	Body Weight Changes 01/2021
1	Body Weight (Weight, Body) 01/2021
1	Exanthema (Rash) 12/2020
1	Celiac Disease (Celiac Sprue) 12/2020
1	Schizophrenia (Dementia Praecox) 10/2020
1	Psychotic Disorders (Schizoaffective Disorder) 10/2020
1	Rheumatoid Arthritis 01/2020
1	Autoimmune Diseases (Autoimmune Disease) 01/2020
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2020

Drug/Important Bio-Agent (IBA)

19	Antiviral Agents (Antivirals)IBA 04/2024 - 12/2016
10	InterferonsIBA 01/2022 - 07/2018
8	SofosbuvirIBA 01/2024 - 12/2018
8	Ribavirin (Virazole)FDA LinkGeneric 01/2022 - 02/2009
6	velpatasvirIBA 01/2024 - 12/2018
4	glecaprevir and pibrentasvirIBA 04/2024 - 12/2018
4	Retinaldehyde (Retinal)IBA 09/2022 - 01/2018
4	Biomarkers (Surrogate Marker)IBA 01/2019 - 05/2015
4	Protein Kinase CIBA 02/2012 - 09/2005
3	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2024 - 02/2009
3	sofosbuvir drug combination ledipasvirIBA 08/2022 - 12/2018
3	RNA (Ribonucleic Acid)IBA 01/2022 - 09/2012
3	peginterferon alfa-2a (Pegasys)FDA Link 12/2020 - 02/2009
3	Malondialdehyde (Propanedial)IBA 01/2019 - 04/2016
3	DNA (Deoxyribonucleic Acid)IBA 04/2018 - 02/2009
2	Metformin (Glucophage)FDA LinkGeneric 04/2024 - 01/2023
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2024 - 01/2023
2	Hepatitis B e AntigensIBA 03/2024 - 07/2018
2	Hemoglobins (Hemoglobin)IBA 01/2024 - 06/2019
2	BilirubinIBA 04/2023 - 01/2022
2	acceleratory factor from growth hormone (AcG)IBA 10/2021 - 01/2021
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 09/2021 - 09/2012
2	Brimonidine Tartrate (Alphagan)FDA LinkGeneric 07/2021 - 01/2021
2	Alanine Transaminase (SGPT)IBA 01/2021 - 09/2012
2	daclatasvirIBA 01/2021 - 12/2018
2	asunaprevirIBA 01/2021 - 12/2018
2	entecavir FDA Link 07/2018 - 12/2016
2	C-Reactive ProteinIBA 04/2016 - 05/2007
2	gadolinium ethoxybenzyl DTPA FDA Link 01/2014 - 10/2010
2	Protein Kinase C-alphaIBA 04/2010 - 09/2005
1	sofosbuvir velpatasvir voxilaprevir drug combinationIBA 04/2023
1	AgarIBA 04/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2022
1	MicroRNAs (MicroRNA)IBA 04/2022
1	Carbonic Anhydrases (Carbonic Anhydrase)IBA 04/2022
1	Antiglaucoma AgentsIBA 04/2022
1	tenofovir alafenamideIBA 01/2021
1	dorzolamide (Trusopt)FDA LinkGeneric 01/2021
1	Carteolol (Carteolol Hydrochloride)FDA LinkGeneric 01/2021
1	Tenofovir (Viread)FDA Link 01/2021
1	CarbohydratesIBA 12/2020
1	Therapeutic UsesIBA 12/2020
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2020
1	Adenine FDA LinkGeneric 01/2020
1	Monoamine Oxidase (MAO)IBA 07/2019

Therapy/Procedure

25	Therapeutics 04/2024 - 10/2008
3	Phacoemulsification 07/2023 - 01/2011
2	Aftercare (After-Treatment) 04/2022 - 02/2009
1	Stents 07/2023
1	Cataract Extraction 10/2021
1	Intraocular Lens Implantation 01/2021
1	Injections 12/2020